# Spiras Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spiras-health

- Industry: Healthcare
- Headquarters: Brentwood, US
- Website: www.spirashealth.com
- Total disclosed funding: $21M
- Latest round: Series B (Nov 4, 2025)
- Investors on record: 9

## About

Founded in 2015 and based in Brentwood, US, Spiras Health, Inc. is a healthcare organization specializing in home-based longitudinal care for patients with complex chronic conditions, focusing on enhancing access to care and improving health outcomes through continuous support. Spiras Health provides a nurse practitioner-led program that caters to patients with complex chronic conditions. The company has undergone no significant changes in its business strategy or operations. David D. Hagaman is the founder, and Scott Bowers serves as the CEO. In November 2025, Spiras Health, Inc. raised USD 6 million in series B funding from new investors Alumni Ventures, Brighton Partners, Primetime Partners and Tamarind Hill. 

Spiras Health offers a nurse practitioner-led program that focuses on providing home-based longitudinal care specifically designed for patients with complex chronic conditions such as Congestive Heart Failure (CHF), Hypertension, Diabetes, and Chronic Obstructive Pulmonary Disease (COPD). The program emphasizes ongoing support and regular touchpoints with members to enhance access to care, reduce emergency room visits, and improve overall health outcomes. Through these services, Spiras Health aims to help patients adhere to prescribed care plans, thereby enhancing their quality of life while managing their chronic illnesses. The primary client base includes health plans and healthcare providers who aim to improve the health outcomes of their polychronic member populations, primarily targeting markets across the United States.

Spiras Health generates revenue through partnerships with healthcare providers and health plans, leveraging a model that focuses on subscription-based services for continuous patient care management. The transactions typically involve contractual agreements where health plans pay Spiras Health to manage care for their members with chronic conditions. These partnerships may include performance-based incentives tied to improved health outcomes and reduced healthcare utilization costs. While specific pricing plans for the services are not disclosed, the revenue structure is aligned with the value provided through improved patient health and satisfaction, central to the company's mission of enhancing care for chronic patients. 

The company plans to use the November 2025 funding to supports expansion into new states, enhancement of care delivery for chronic conditions, and product development, reflecting investor confidence in scalable home-based healthcare solutions.

## Funding rounds

- Series B, Nov 4, 2025, $6M — Brighton Partners, Alumni Ventures Group, Tamarind Hill, Primetime Partners
- Series B, Jun 22, 2021, $14M — New Enterprise Associates, Clayton Associates, Altitude Ventures, FCA Venture Partners
- Series A, Jun 22, 2015, $0.8M — Clayton Associates, Altitude Ventures, Jumpstart Health Investors
- Seed, May 14, 2015, $0.1M — Jumpstart Health Investors

## Investors

- Jumpstart Health Investors (https://capitalatlas.ai/funds/jumpstart-health-investors) — Seed, Series A
- Clayton Associates (https://capitalatlas.ai/funds/clayton-associates) — Series A, Series B
- Altitude Ventures (https://capitalatlas.ai/funds/altitude-ventures) — Series A, Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B
- FCA Venture Partners (https://capitalatlas.ai/funds/fca-venture-partners) — Series B
- Brighton Partners (https://capitalatlas.ai/funds/brighton-partners) — Series B
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series B
- Tamarind Hill (https://capitalatlas.ai/funds/tamarind-hill) — Series B
- Primetime Partners (https://capitalatlas.ai/funds/primetime-partners) — Series B